Delivery Order SPE2DR25D2212-SPE2DR26FB9PY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,039.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,310.10 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,294.68 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded on a full and open basis. The product will be delivered to the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.86 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count), with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.39 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 37.5mg capsules (100 count) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,237.50 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count bottles). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by December 23, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,088.78 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,014.76 for Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on October 29, 2025, with completion scheduled for October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's broader federal pharmaceutical supply agreements. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,167.17 to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9PYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,986.62 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitive award, which carries no set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a firm fixed-price delivery order executed under AmerisourceBergen Drug Corp's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Department of Defense and military healthcare systems. The company maintains a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which enables comprehensive global pharmaceutical supply support to military treatment facilities and other federal healthcare programs. This delivery order for controlled pharmaceutical substances reflects the company's extensive portfolio in supplying medications across multiple therapeutic domains to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/7/26 |